Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study

NCT02620618 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT02620618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
Lead sponsor
Cairo University
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2014
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

behçet's disease, uveitis